BCRX
Price
$10.37
Change
-$0.03 (-0.29%)
Updated
Jun 13 closing price
Capitalization
2.17B
46 days until earnings call
VKTX
Price
$26.08
Change
-$2.50 (-8.75%)
Updated
Jun 13 closing price
Capitalization
2.93B
38 days until earnings call
Interact to see
Advertisement

BCRX vs VKTX

Header iconBCRX vs VKTX Comparison
Open Charts BCRX vs VKTXBanner chart's image
BioCryst Pharmaceuticals
Price$10.37
Change-$0.03 (-0.29%)
Volume$2.66M
Capitalization2.17B
Viking Therapeutics
Price$26.08
Change-$2.50 (-8.75%)
Volume$6.1M
Capitalization2.93B
BCRX vs VKTX Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. VKTX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a StrongBuy and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (BCRX: $10.37 vs. VKTX: $26.08)
Brand notoriety: BCRX: Notable vs. VKTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 53% vs. VKTX: 165%
Market capitalization -- BCRX: $2.17B vs. VKTX: $2.93B
BCRX [@Biotechnology] is valued at $2.17B. VKTX’s [@Biotechnology] market capitalization is $2.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 1 bullish TA indicator(s).

  • BCRX’s TA Score: 3 bullish, 5 bearish.
  • VKTX’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than VKTX.

Price Growth

BCRX (@Biotechnology) experienced а -6.07% price change this week, while VKTX (@Biotechnology) price change was -6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.93B) has a higher market cap than BCRX($2.17B). BCRX YTD gains are higher at: 37.899 vs. VKTX (-35.189). BCRX has higher annual earnings (EBITDA): 47.6M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. BCRX (295M). VKTX has less debt than BCRX: VKTX (1M) vs BCRX (795M). BCRX has higher revenues than VKTX: BCRX (503M) vs VKTX (0).
BCRXVKTXBCRX / VKTX
Capitalization2.17B2.93B74%
EBITDA47.6M-171.93M-28%
Gain YTD37.899-35.189-108%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295M852M35%
Total Debt795M1M79,500%
FUNDAMENTALS RATINGS
BCRX vs VKTX: Fundamental Ratings
BCRX
VKTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
40
Fair valued
PROFIT vs RISK RATING
1..100
7076
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
3986
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (32) in the Biotechnology industry is in the same range as VKTX (40). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

BCRX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as VKTX (76). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as BCRX (100). This means that VKTX’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for VKTX (86). This means that BCRX’s stock grew somewhat faster than VKTX’s over the last 12 months.

BCRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VKTX (100). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend about 1 month ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCE41.440.83
+2.06%
Invesco S&P SmallCap Energy ETF
NFXS13.900.04
+0.29%
Direxion Daily NFLX Bear 1X Shares
MYD9.96-0.04
-0.36%
Blackrock Muniyield Fund
IJAN33.83-0.18
-0.53%
Innovator Itnl Dvp Pwr Buff ETF™ Jan
FXR71.59-1.38
-1.89%
First Trust Indtls/PrdcrDurbAlphaDEX®ETF

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with CRNX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-0.29%
CRNX - BCRX
39%
Loosely correlated
-1.24%
VKTX - BCRX
39%
Loosely correlated
-8.75%
HOWL - BCRX
39%
Loosely correlated
-5.43%
ARWR - BCRX
39%
Loosely correlated
-2.96%
BEAM - BCRX
38%
Loosely correlated
-2.18%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with GPCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-8.75%
GPCR - VKTX
50%
Loosely correlated
-2.43%
CRNX - VKTX
48%
Loosely correlated
-1.24%
KRYS - VKTX
47%
Loosely correlated
-2.32%
ROIV - VKTX
46%
Loosely correlated
-1.31%
ALT - VKTX
45%
Loosely correlated
-3.22%
More